These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 37410387)

  • 61. The Lymphangioleiomyomatosis Lung Cell and Its Human Cell Models.
    Steagall WK; Pacheco-Rodriguez G; Darling TN; Torre O; Harari S; Moss J
    Am J Respir Cell Mol Biol; 2018 Jun; 58(6):678-683. PubMed ID: 29406787
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Lymphangioleiomyomatosis Association with Underlying Genotype in Patients with Tuberous Sclerosis Complex.
    Tian X; Glass JE; Kwiatkowski DJ; Towbin AJ; Li Y; Sund KL; Krueger DA; Franz DN; McCormack FX; Gupta N
    Ann Am Thorac Soc; 2021 May; 18(5):815-819. PubMed ID: 33171065
    [No Abstract]   [Full Text] [Related]  

  • 63. Detection of low-prevalence somatic TSC2 mutations in sporadic pulmonary lymphangioleiomyomatosis tissues by deep sequencing.
    Fujita A; Ando K; Kobayashi E; Mitani K; Okudera K; Nakashima M; Miyatake S; Tsurusaki Y; Saitsu H; Seyama K; Miyake N; Matsumoto N
    Hum Genet; 2016 Jan; 135(1):61-8. PubMed ID: 26563443
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Analysis of gene expression array in TSC2-deficient AML cells reveals IRF7 as a pivotal factor in the Rheb/mTOR pathway.
    Makovski V; Jacob-Hirsch J; Gefen-Dor C; Shai B; Ehrlich M; Rechavi G; Kloog Y
    Cell Death Dis; 2014 Dec; 5(12):e1557. PubMed ID: 25476905
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Human Pluripotent Stem Cell-Derived
    Julian LM; Delaney SP; Wang Y; Goldberg AA; Doré C; Yockell-Lelièvre J; Tam RY; Giannikou K; McMurray F; Shoichet MS; Harper ME; Henske EP; Kwiatkowski DJ; Darling TN; Moss J; Kristof AS; Stanford WL
    Cancer Res; 2017 Oct; 77(20):5491-5502. PubMed ID: 28830860
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Pulmonary lymphangioleiomyomatosis (LAM)].
    Theegarten D; Hager T
    Pathologe; 2021 Feb; 42(1):35-39. PubMed ID: 33420570
    [TBL] [Abstract][Full Text] [Related]  

  • 67. TSC1 and TSC2 mutations in patients with lymphangioleiomyomatosis and tuberous sclerosis complex.
    Muzykewicz DA; Sharma A; Muse V; Numis AL; Rajagopal J; Thiele EA
    J Med Genet; 2009 Jul; 46(7):465-8. PubMed ID: 19419980
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Minireview: Lymphangioleiomyomatosis (LAM): The "Other" Steroid-Sensitive Cancer.
    Prizant H; Hammes SR
    Endocrinology; 2016 Sep; 157(9):3374-83. PubMed ID: 27409646
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Targeted approaches toward understanding and treating pulmonary lymphangioleiomyomatosis (LAM).
    Hammes SR; Krymskaya VP
    Horm Cancer; 2013 Apr; 4(2):70-7. PubMed ID: 23184699
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pathogenesis of multifocal micronodular pneumocyte hyperplasia and lymphangioleiomyomatosis in tuberous sclerosis and association with tuberous sclerosis genes TSC1 and TSC2.
    Maruyama H; Ohbayashi C; Hino O; Tsutsumi M; Konishi Y
    Pathol Int; 2001 Aug; 51(8):585-94. PubMed ID: 11564212
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Estradiol promotes pentose phosphate pathway addiction and cell survival via reactivation of Akt in mTORC1 hyperactive cells.
    Sun Y; Gu X; Zhang E; Park MA; Pereira AM; Wang S; Morrison T; Li C; Blenis J; Gerbaudo VH; Henske EP; Yu JJ
    Cell Death Dis; 2014 May; 5(5):e1231. PubMed ID: 24832603
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Signal transducer and activator of transcription 3 is required for abnormal proliferation and survival of TSC2-deficient cells: relevance to pulmonary lymphangioleiomyomatosis.
    Goncharova EA; Goncharov DA; Damera G; Tliba O; Amrani Y; Panettieri RA; Krymskaya VP
    Mol Pharmacol; 2009 Oct; 76(4):766-77. PubMed ID: 19596836
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Rapalog resistance is associated with mesenchymal-type changes in Tsc2-null cells.
    Valianou M; Filippidou N; Johnson DL; Vogel P; Zhang EY; Liu X; Lu Y; Yu JJ; Bissler JJ; Astrinidis A
    Sci Rep; 2019 Feb; 9(1):3015. PubMed ID: 30816188
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Evidence that lymphangiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis.
    Smolarek TA; Wessner LL; McCormack FX; Mylet JC; Menon AG; Henske EP
    Am J Hum Genet; 1998 Apr; 62(4):810-5. PubMed ID: 9529362
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The spectrum of mutations in TSC1 and TSC2 in women with tuberous sclerosis and lymphangiomyomatosis.
    Strizheva GD; Carsillo T; Kruger WD; Sullivan EJ; Ryu JH; Henske EP
    Am J Respir Crit Care Med; 2001 Jan; 163(1):253-8. PubMed ID: 11208653
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Lymphangioleiomyomatosis (LAM): molecular insights lead to targeted therapies.
    Glasgow CG; Steagall WK; Taveira-Dasilva A; Pacheco-Rodriguez G; Cai X; El-Chemaly S; Moses M; Darling T; Moss J
    Respir Med; 2010 Jul; 104 Suppl 1(Suppl 1):S45-58. PubMed ID: 20630348
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Connectivity Map Analysis of a Single-Cell RNA-Sequencing -Derived Transcriptional Signature of mTOR Signaling.
    Al Mahi N; Zhang EY; Sherman S; Yu JJ; Medvedovic M
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922083
    [TBL] [Abstract][Full Text] [Related]  

  • 78. TSC2 loss in lymphangioleiomyomatosis cells correlated with expression of CD44v6, a molecular determinant of metastasis.
    Pacheco-Rodriguez G; Steagall WK; Crooks DM; Stevens LA; Hashimoto H; Li S; Wang JA; Darling TN; Moss J
    Cancer Res; 2007 Nov; 67(21):10573-81. PubMed ID: 17975002
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Neutrophil elastase from myeloid cells promotes TSC2-null tumor growth.
    Taya M; Garcia-Hernandez ML; Rangel-Moreno J; Minor B; Gibbons E; Hammes SR
    Endocr Relat Cancer; 2020 Apr; 27(4):261-274. PubMed ID: 32045362
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Dysregulation of the endothelin pathway in lymphangioleiomyomatosis with no direct effect on cell proliferation and migration.
    Chebib N; Archer F; Bobet-Erny A; Leroux C; Cottin V
    Sci Rep; 2018 Oct; 8(1):14698. PubMed ID: 30279475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.